Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Rare Disease Canada
    Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Vaccines Italy
    Projects for Enhancing Regional Cancer Treatment
    Release Date:
    Partner: Japanese Society of Clinical Oncology
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Oncology Japan
    Sickle Cell Disease (SCD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Cancer Registry
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Research Oncology Congo, The Democratic Republic
    The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Improving the Therapeutic Environment for Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Oncology Japan
    Shared Decision-Making (SDM) in Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Oncology Japan
    Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    New Mechanisms and Emerging Treatment Options in Metastatic Breast Cancer
    Release Date:
    Partner: Arvinas
    Review Process: Pfizer Internal
    Education Oncology All